Recomienda este artículo a tus amigos:
Coronavirus Drug Discovery: Volume 3: Druggable Targets and In Silico Update - Drug Discovery Update Elsevier Science
Pedido desde almacén remoto
Nuestros clientes opinan:
Coronavirus Drug Discovery: Volume 3: Druggable Targets and In Silico Update - Drug Discovery Update
Elsevier Science
Coronavirus Drug Discovery, Volume 3: Druggable Targets and In Silico Update is the third of three volumes presenting comprehensive information on drug discovery against COVID-19. The chapters in part one of this volume describe the various druggable targets and associated signaling pathways for effective targeting of SARS-CoV-2. In part two, chapters discuss the various computational approaches and in silico studies against SARS-CoV-2. Written by global team of experts, this book is an excellent resource that will be extremely useful to drug developers, medicinal chemists, pharmaceutical companies in R& D, research institutes in both academia and industry, and the National Library of Medicines and Health. Also, agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, European Medicines Agency, the US Food and Drug Administration, and all others involved in drug discovery against COVID-19 will find this book useful.
406 pages
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 12 de julio de 2022 |
| ISBN13 | 9780323955782 |
| Editores | Elsevier - Health Sciences Division |
| Páginas | 406 |
| Dimensiones | 150 × 220 × 10 mm · 539 g |
| Lengua | Inglés |
| Editor | Egbuna, Chukwuebuka (Chukwuemeka Odumegwu Ojukwu University, Nigeria.) |
Mas por Elsevier Science
Mostrar todo
Mere med samme udgiver
Ver todo de Elsevier Science ( Ej. Paperback Book y Hardcover Book )